Ambalal Sarabhai Enterprises Ltd

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is to inform that on June 8 2023 Asence Pharma Pvt. Ltd. a subsidiary of the Company has commenced its new oncology and synthetic API plant at Ranoli Vadodara. The detailed announcement enclosed herewith. You are requested to take the same on your record.